Schimmelpennink Evert B., President, CEO and Secretary, Director at LENZ Therapeutics, Inc., bought $251K of LENZ

Schimmelpennink Evert B. President, CEO and Secretary, Director

LENZ Therapeutics, Inc. · $LENZ

$251K Total Value

28,089 Shares Traded

$8.9505 Price / Share

77,289 Shares Owned After

2026-03-30 Filing Date

Transaction Details

Insider	Schimmelpennink Evert B.
Title	President, CEO and Secretary, Director
Company	LENZ Therapeutics, Inc.
Ticker	LENZ
Transaction Type	Purchase
Transaction Date	2026-03-27
Shares Traded	28,089
Price Per Share	$8.9505
Total Value	$251K
Filed Date	2026-03-30
Accession Number	0001713795-26-000004

Ownership Context

Shares Owned After Transaction	77,289
Ownership Type	Direct

SEC Filing

↗ View Original SEC Filing

Accession: 0001713795-26-000004

Other Insider Trades — LENZ

Insider	Title	Action	Value	Date
RA CAPITAL MANAGEMENT, L.P.	Insider	traded	—	2026-06-15
MCCOLLUM JAMES W	Director	traded	—	2026-06-15
Thunen Shelley B	Director	traded	—	2026-06-15
Scheiner Zachary	Director	traded	—	2026-06-15
George Jeffrey P.	Director	traded	—	2026-06-15
Guerard Frederic	Director	traded	—	2026-06-15
Drapkin Kimberlee C	Director	traded	—	2026-06-15
George Jeffrey P.	Director	bought	$50K	2026-03-27
Chevallard Daniel R.	Chief Financial Officer	bought	$64K	2026-03-27

Full Ticker Profile

View all insider trades, dark pool activity, congressional filings, and the Whisper Score for LENZ — LENZ Therapeutics, Inc. →

Track LENZ insider activity in real time on The Wire →

Get alerts when Schimmelpennink Evert B. files new trades — Go Pro →

Data sourced from SEC Form 4 insider trading filings. Transaction details are as reported to the Securities and Exchange Commission. This page does not constitute financial advice. StonkWhisper presents public records — it does not verify or guarantee the accuracy of SEC filings.

Last updated: June 16, 2026 at 07:22 UTC